News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Ariad (ARIA) IDERA (IDRA) Inovio (INO) SYNTA (SNTA) ZALTRAP™ TOKAI (TKAOI) Regeneron (REGN) Intrexon (XON) Sequenom (SQNM) ARCA (ABIO) Ziofpharm (ZIOP) Sanofi (SNY) AstraZeneca (AZN) Ionis (IONS) Anadys (ANDS) GUARDIAN HEALTH BIOMARIN (BMRN) SUNESIS PHARMACEUTICALS (SNSS) Mirati Therapeutics (MRTX) KITE (KITE) OncoCyte (OCX) Roche (ROCHE) Prolor Biotech (PBTH) VANDA (VNDA) Auspex (ASPX) MODERNA Human Longevity (HLI) ADVENTRIX (ANX) Sangamo (SGMO) JOUNCE THERAPEUTICS (JNCE) Vitae Pharmaceuticals (VTAE) Bristol-Myers Squibb (BMY) PTC Therapeutics (PTCT) Incyte (INCY) Sanofi-Aventis (SAN) INNOVIVA (INVA) Array Pharmaceuticals (ARRY) Exelixis (EXEL) Dendreon (DNDN) KERYX (KERX) Ocular Therapeutix (OCUL) Benlysta (belimumab) C4 Therapeutics ARGOS (ARGS) Multiple Myeloma NEKTAR (NKTR)) Agenus (AGEN Theravance (THRX) Amgen (AMGN) Intercept (ICPT) OSI (OSIP) Biocryst (BCRX) Gilead (GILD) Jazz Pharmaceuticals (JAZZ) AERIE PHARMACEUTICALS Anacor (ANAC) Zerenex Prosensa (RNA) Ridaforolimus Roche (RHHBY) Tysabri Vertex (VRTX) RenenxBio (RGNX) Onyx (ONXX) Galena (GALE) REGULUS (RGLS) CompuGen (CGEN) Idenix (IDIX) Velcade (bortezomib) Alnylam (ALNY) Merck (MRK) CEMPRA (CEMP) Micromet (MITI) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) AGOS (ARGS) NEUROCRINE (NBIX) NOVOCURE (NVCR) Pluristem (PSTI) Valeant Pharmaceuticals International (VRX) Rapamune Revlimid (lenolidamide) Seattle Genetics (SGEN) Sarepta (SRPT) PORTOLA (PTLA) Biogen Idec (BIIB) NANTKWEST (NK) Cytokinetics (CYTK) Herceptin Trastuzumab-DM1 Bellicum (BLCM) Xoma (XOMA) Intermune (ITMN) Aimmune Therapeutics (AIMT) Advaxis (ADXS) Editas (EDIT) Global Cell Therapeutics (GBT) Illumina (ILMN) ImmunoGen (IMGN) Endometrial Cancer Sanofi (SNA) Human Genome Sciences (HGSI) Spike Therapeutics (ONCE) ACADIA (ACAD) ISIS (ISIS) galapagos (GLPG) Agenus (AGEN) LEXICON (LXRX) JUNO (JUNO) CRISPR Therapeutics (CRSP) Dynavax (DVAX) Theravance Bio Pharma (TBPH) Telaprevir Elan (ELN) Genentech Alder Biopharmaceuticals (ALDR) ABBVIE (ABBV) GlaxoSmithKline (GSK) Adaptimmune (ADAP) Abbott Laboratories (ABT)